Senseonics to Participate in the H.C. Wainwright Global Life Sciences Conference

Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE American: SENS) announced its participation in the virtual H.C. Wainwright Global Life Sciences Conference on March 9, 2021. Management will engage in one-on-one meetings and a presentation webcast will be available at 7:00am ET on the same day. The webcast can be accessed via the Investor Relations section of their website. Senseonics is dedicated to developing innovative continuous glucose monitoring systems aimed at improving the quality of life for diabetes patients, featuring their Eversense® and Eversense® XL products.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming virtual H.C. Wainwright Global Life Sciences Conference.

Management is scheduled to participate and hold one-on-one meetings Tuesday, March 9, 2021. A presentation webcast will be available in advance of the event on the same morning at 7:00am ET. Interested parties may access a recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM systems, Eversense^® and Eversense^® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302006168/en/

FAQ

When is Senseonics participating in the H.C. Wainwright Global Life Sciences Conference?

Senseonics is participating on March 9, 2021.

What time will the Senseonics presentation webcast be available?

The webcast will be available at 7:00am ET on March 9, 2021.

Where can I access the Senseonics conference presentation?

The presentation can be accessed in the Investor Relations section of Senseonics' website.

What is the focus of Senseonics' technology?

Senseonics focuses on long-term, implantable continuous glucose monitoring systems for diabetes management.

What products does Senseonics offer?

Senseonics offers the Eversense® and Eversense® XL continuous glucose monitoring systems.